14,474 results found

FDA recently convened a joint advisory committee meeting on testosterone replacement therapy.

On August 6, 2025, the U.S. Food and Drug Administration (FDA) became the latest governmental agency to confirm that fluoropolymers are both safe and necessary.

In the April 25, 2016, Federal Register, FDA proposed a ban on electrical stimulation devices used to treat aggressive or self-injurious behavior.

In the July 24, 2015, Federal Register, FDA issued a proposed rule to amend the proposed rule, "Accreditation of Third-Party Auditors/Certification Bodies to Conduct Food Safety Audits and to Issue Certifications."

In the same notice, FDA is proposing to amend its existing "intended use" regulations for drugs and devices.

As discussed above, in the November 18, 2015, Federal Register, FDA proposed to establish additional requirements concerning "gluten-free" labelling...

The requirement would apply to information material to the admissibility determination for FDA-regulated products being imported or offered for import.

According to FDA, it has been implementing the MMA directly from the statute for several years and now seeks to amend its regulations to codify current practice and policy.

In the April 9, 2015, Federal Register, FDA announced its proposal to amend regulations for registration of foreign food facilities that manufacture/process, pack, or hold food for human or animal consumption in the United States.

In the July 2, 2015, Federal Register, FDA proposed to remove two regulations dictating procedures for FDA's review and classification of biological products licensed before July 1, 1972.

On January 16, 2014, the Food and Drug Administration (FDA) issued a final guidance document for industry providing specific recommendations on the content and format of Dear Health Care Provider (DHCP or "Dear Doctor") letters.

In the September 10, 2015, Federal Register, FDA announced the fees for issuing export certifications for animal food, which may reach up to $175 for each certificate.

In the September 21, 2015, Federal Register, FDA announced the availability of a draft Compliance Policy Guide ("CPG") titled "Compliance Policy Guide Sec. 100.101 Crotalaria spp. Seeds in Grains."

In the May 18, 2015, Federal Register, FDA published draft recommendations for sponsors' use when creating Study Data Standardization Plans.

In the February 11, 2015, Federal Register, FDA published a list of premarket approval applications that were approved between July 1, 2014, and September 30, 2014.

In the November 18, 2015, Federal Register, FDA published a list of premarket approval applications ("PMAs") that have been approved between July 1, 2015, and September 30, 2015.

In the September 10, 2015, Federal Register, FDA announced the availability of documents updating the administrative docket of the proposed rule amending FDA's labeling regulations for conventional foods and dietary supplements.